MX2014014460A - Peptidos de cladosporium. - Google Patents

Peptidos de cladosporium.

Info

Publication number
MX2014014460A
MX2014014460A MX2014014460A MX2014014460A MX2014014460A MX 2014014460 A MX2014014460 A MX 2014014460A MX 2014014460 A MX2014014460 A MX 2014014460A MX 2014014460 A MX2014014460 A MX 2014014460A MX 2014014460 A MX2014014460 A MX 2014014460A
Authority
MX
Mexico
Prior art keywords
seq
amino acid
cladosporium
peptides
acid sequence
Prior art date
Application number
MX2014014460A
Other languages
English (en)
Inventor
Paul Laidler
Roderick Peter Hafner
Pascal Hickey
Mark Larche
Original Assignee
Circassia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Circassia Ltd filed Critical Circassia Ltd
Publication of MX2014014460A publication Critical patent/MX2014014460A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01138—Mannitol 2-dehydrogenase (NADP+) (1.1.1.138)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/01—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
    • C12Y102/01003—Aldehyde dehydrogenase (NAD+) (1.2.1.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y402/00—Carbon-oxygen lyases (4.2)
    • C12Y402/01—Hydro-lyases (4.2.1)
    • C12Y402/01011—Phosphopyruvate hydratase (4.2.1.11), i.e. enolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)

Abstract

Se proporcionan péptidos los cuales se pueden utilizar para evitar o tratar alergia a mohos de los géneros Cladosporium y/o Alternaria, que tienen una longitud de hasta 30 aminoácidos y que comprenden: (I) la secuencia de aminoácidos: (a) GGYKAAVRPTMLE (SEC ID NO: 35; Cla35), (b) AE V YQKLK SLTKK (SEC ID NO: 31; Cla16), (c) VAITYASRAQGAE (SEC ID NO: 32; Cla 25), (d) GHHFKERGT-GSLVIT (SEC ID NO: 33; Cla26), o (e) ANYTQTKTVSIRL (SEC ID NO: 34; Cla29); o (II) una secuencia variante que contiene epítopo para linfocitos T la cual es una secuencia de aminoácidos (I) que tiene hasta seis modificaciones de aminoácidos, cada una de las cuales es independientemente una supresión, sustitución o inserción.
MX2014014460A 2012-06-01 2013-05-30 Peptidos de cladosporium. MX2014014460A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1209862.0A GB201209862D0 (en) 2012-06-01 2012-06-01 Cladosporium peptides
PCT/GB2013/051440 WO2013179044A2 (en) 2012-06-01 2013-05-30 Cladosporium peptides

Publications (1)

Publication Number Publication Date
MX2014014460A true MX2014014460A (es) 2015-02-12

Family

ID=46582262

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014014460A MX2014014460A (es) 2012-06-01 2013-05-30 Peptidos de cladosporium.

Country Status (16)

Country Link
US (1) US9850281B2 (es)
EP (1) EP2855514A2 (es)
JP (1) JP2015520171A (es)
KR (1) KR20150016622A (es)
CN (1) CN104507960A (es)
AU (1) AU2013269327A1 (es)
BR (1) BR112014029834A2 (es)
CA (1) CA2875131A1 (es)
CL (1) CL2014003289A1 (es)
EA (1) EA201492270A1 (es)
GB (2) GB201209862D0 (es)
HK (1) HK1202554A1 (es)
IL (1) IL235842A0 (es)
MX (1) MX2014014460A (es)
SG (1) SG11201407945SA (es)
WO (1) WO2013179044A2 (es)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT400722B (de) * 1993-08-27 1996-03-25 Biomay Prod & Handel Rekombinante cladosporium herbarum allergene
AT401181B (de) 1994-11-02 1996-07-25 Biomay Prod & Handel Rekombinante dna moleküle
AT403166B (de) * 1995-03-02 1997-11-25 Biomay Prod & Handel Rekombinante dna moleküle, die für polypeptide kodieren, die die antigenität der allergene clah8 und clah12 besitzen
CA2217173C (en) 1997-11-25 2008-04-01 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Health Isolation of a cdna clone encoding a subunit of the alternaria alternata major allergen alt a 1, and production of recombinant protein thereof
WO2003083098A2 (de) 2002-03-28 2003-10-09 Biomay Produktions- Und Handels-Aktiengesellschaft Nucleinsäuresequenz und protein sowie polypeptide kodierend für mannit-dehydrogenasen oder deren teile sowie deren herstellung und verwendung in diagnostik und therapie
WO2009022154A2 (en) 2007-08-15 2009-02-19 Circassia Limited Peptide with multiple epitopes
CN101178406A (zh) 2007-12-05 2008-05-14 杭州浙大生物基因工程有限公司 过敏原特异性抗体IgE ELISA检测试剂盒及其制备方法
WO2010018384A1 (en) * 2008-08-15 2010-02-18 Circassia Limited T-cell antigen peptide from allergen for stimulation of il-10 production
CN101387643A (zh) 2008-10-20 2009-03-18 杭州浙大生物基因工程有限公司 多通道过敏原快速检测试剂盒及其制备方法
CN101393215A (zh) 2008-11-17 2009-03-25 杭州浙大生物基因工程有限公司 多通道吸入型过敏原快速检测试剂盒及其制备方法
GB0821806D0 (en) 2008-11-28 2009-01-07 Circassia Ltd Compositions with reduced dimer formation
GB201002559D0 (en) 2010-02-15 2010-03-31 Circassia Ltd Birch peptides for vaccine
CN102212531A (zh) 2010-04-02 2011-10-12 复旦大学 一种重组多主枝孢霉变应原Cla h8蛋白的制备方法及其用途
BR112013009068A2 (pt) 2010-10-15 2016-07-19 Alk Abelló As supressão de uma resposta imune de hipersensibilidade com antígeno não relacionado derivado de material fonte de alérgeno
US20150004189A1 (en) * 2012-02-07 2015-01-01 La Jolla Institute For Allergy And Immunology Epitopes from allergen proteins and methods and uses for immune response modulation

Also Published As

Publication number Publication date
EA201492270A1 (ru) 2015-09-30
GB2518092A (en) 2015-03-11
JP2015520171A (ja) 2015-07-16
US20150218215A1 (en) 2015-08-06
WO2013179044A3 (en) 2014-03-06
BR112014029834A2 (pt) 2017-07-25
KR20150016622A (ko) 2015-02-12
AU2013269327A1 (en) 2014-12-18
SG11201407945SA (en) 2014-12-30
US9850281B2 (en) 2017-12-26
GB201209862D0 (en) 2012-07-18
CN104507960A (zh) 2015-04-08
CL2014003289A1 (es) 2015-05-22
CA2875131A1 (en) 2013-12-05
WO2013179044A2 (en) 2013-12-05
IL235842A0 (en) 2015-01-29
EP2855514A2 (en) 2015-04-08
HK1202554A1 (en) 2015-10-02

Similar Documents

Publication Publication Date Title
TN2017000085A1 (en) Polypeptide having a polyester degrading activity and uses thereof
NZ628625A (en) Polypeptides binding to human complement c5
NZ707439A (en) Modified factor ix polypeptides and uses thereof
SA518390954B1 (ar) لقاحات علاجية لفيروس الورم الحليمي البشري 18
AR093903A1 (es) Coagonistas de glucagon y glp-1 para el tratamiento de la obesidad
ES2531290T3 (es) Transferasas y oxidorreductasas, ácidos nucleicos que las codifican y métodos para prepararlas y usarlas
AR092076A1 (es) Proteinas homodimericas
UA118167C2 (uk) Пептид та його застосування
MX2017009595A (es) Compuestos antisenescentes y usos de los mismos.
PH12016500101A1 (en) Protease-resistant peptide ligands
PE20220960A1 (es) Proteinas de variantes de secuencias de aminoacidos de cry1da1 activas para lepidopteros
NZ602845A (en) Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
NZ750559A (en) Complete genome sequence of the methanogen methanobrevibacter ruminantium
MX2015003310A (es) Moleculas de union il-17a novedosas y usos medicos de las mismas.
NZ604412A (en) Vaccine and methods to reduce campylobacter infection
AR120721A2 (es) Péptidos y composiciones para el tratamiento de daño articular
MX360187B (es) Uso de polipeptidos derivados de pedf para promover la regeneración de músculo o tendón o arteriogénesis.
MX2019006943A (es) Polipéptidos para manejo de infecciones virales.
RS54422B1 (en) APOPTOSIS INHIBITORS AND THEIR USES
PH12017502323A1 (en) Novel xylanase
EA201591609A1 (ru) Варианты альфа-амилазы
EA201590601A1 (ru) Применение pedf-производных полипептидов для лечения остеоартрита
MY195726A (en) Steviol Glycoside Transport
GB2517354A (en) Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy
AR119056A2 (es) Péptido de fusión, polinucleótido que lo codifica, vector y célula transformada